Re:Cognition Health Renews Global Clinical Site Certification at U.S. Clinics
Re:Cognition Health has successfully renewed its Global Clinical Site Assessment (GCSA) Site Certification at its four U.S. clinics located in Fairfax, Virginia; Chicago, Illinois; Houston, Texas; and Fort Worth, Texas. This certification, awarded by the International Accrediting Organization for Clinical Research (IAOCR), is a globally recognized standard for clinical research sites. Re:Cognition Health initially received this certification in 2024, becoming the first organization to achieve it in both the U.S. and Europe. The clinics are currently conducting 60 clinical trials related to various conditions, including Alzheimer's Disease and Bipolar Disorder.